Patient summary: The ADA and ADA/EASD diabetes guidelines show that modern diabetes care is no longer only about lowering blood sugar. A1C is still important, but doctors now also consider heart health, kidney health, weight, low blood sugar risk, liver health, medication safety, cost, access, and the patient's daily life.
Diabetes care has changed a lot over the years.
In the past, many people with type 2 diabetes mainly heard about blood sugar numbers, A1C, cholesterol, blood pressure, diet, and exercise. These are still very important. But modern ADA and ADA/EASD-style diabetes care looks at the whole person, not only the glucose number.
This is why two patients with the same A1C may not always receive the same treatment plan.
Your doctor may choose or adjust diabetes treatment based on your:
Important medical note: This page explains ADA and ADA/EASD diabetes guidelines in simple patient language. It does not replace personal medical advice. Do not stop, start, or change diabetes medication without speaking with your doctor, especially if you use insulin, sulfonylureas, SGLT2 inhibitors, GLP-1 medicines, blood pressure medication, or have kidney disease, heart disease, liver disease, pregnancy, or frequent low blood sugar.
How have diabetes guidelines changed over the past 25 years? Explore the historical development of the American Diabetes Association (ADA) Standards of Care, from diabetes prevention and diagnostic criteria to modern cardiovascular protection, kidney care, weight management, and diabetes technology.
Our historical archive is organized into five periods. Each article explains the major clinical developments and why they mattered.
Important distinction: The ADA publishes annual Standards of Care in Diabetes. ADA/EASD consensus reports are separate joint publications released in selected years, not annually.
The Diabetes Prevention Program, revised impaired fasting glucose criteria, and foundations of comprehensive diabetes care.
ADA Guidelines History 2000–2004The 2006 ADA/EASD treatment algorithm, intensive glucose-control trials, and individualized A1C goals.
ADA Guidelines History 2005–2009A1C becomes an accepted ADA diagnostic criterion in 2010, followed by the patient-centered ADA/EASD position statement in 2012.
ADA Guidelines History 2010–2014Cardiovascular outcome trials, SGLT2 inhibitors, GLP-1 receptor agonists, and the 2018 ADA/EASD consensus.
ADA Guidelines History 2015–2019Continuous glucose monitoring, time in range, heart and kidney protection, weight management, and the 2022 ADA/EASD consensus.
ADA Guidelines History 2020–2024Historical education: These articles explain how diabetes recommendations evolved. Current medical decisions should follow the latest ADA Standards of Care and individualized professional advice.
The American Diabetes Association, also called the ADA, publishes the Standards of Care in Diabetes. These standards are updated regularly and are used by healthcare professionals to guide diabetes diagnosis, treatment, monitoring, prevention, and complication care.
The European Association for the Study of Diabetes, also called EASD, has worked with the ADA on important consensus reports, including the ADA/EASD consensus report on the management of hyperglycaemia in type 2 diabetes.
For patients, the most important message is simple:
ADA and ADA/EASD guidelines are not one fixed rule for every patient. They help doctors personalize diabetes care based on the patient's full health picture.
Your diabetes plan should be based on your blood sugar, A1C, kidney function, heart risk, body weight, medication safety, lifestyle, and treatment goals.
Diabetes guidelines have evolved over time, while keeping individualized care at their core. ADA guidance from 2011–2012 already recognized that A1C targets should reflect each person’s health, risk of low blood sugar, and treatment needs.
More recent ADA Standards of Care and ADA/EASD recommendations build on that foundation. Alongside blood sugar management, they emphasize heart and kidney protection, weight management, and treatment choices that fit the person’s overall health and daily life.
Depending on individual needs, care may also include continuous glucose monitoring, assessment of liver health, medication safety, and support for diabetes distress. Cost, access, and personal preferences help shape a plan that is practical to follow.
The main message:
Older diabetes care often asked: "How do we lower blood sugar?"
Modern ADA and ADA/EASD-style care asks: "How do we lower blood sugar safely while also protecting the heart, kidneys, weight, liver, quality of life, and long-term health?"
| Older ADA Guideline Focus: 2011/2012 | Modern ADA and ADA/EASD Guideline Focus |
|---|---|
| A1C was important, and treatment was becoming more individualized. | A1C remains important, but care is personalized around the whole patient. |
| Blood sugar, LDL cholesterol, and blood pressure were major priorities. | Blood sugar, cardiovascular health, kidneys, weight, liver health, and treatment safety are considered together. |
| Medication decisions were often more step-by-step. | Medication selection may depend earlier on heart disease, kidney disease, obesity, and hypoglycemia risk. |
| Gestational diabetes screening and pregnancy follow-up were important. | Pregnancy safety, medication review, and individualized care remain essential. |
| Self-care and patient education were encouraged. | Shared decision-making, cost, access, sleep, mental health, nutrition, and individual preferences receive more attention. |
A1C shows your estimated average blood sugar over approximately the past two to three months. It is one of the most useful tests in diabetes care.
For many nonpregnant adults with diabetes, an A1C goal around 7% is commonly used. However, this goal is not right for everyone.
Some patients may need a lower A1C goal if it can be reached safely. Others may need a less strict goal because of age, serious medical conditions, recurrent hypoglycemia, or risks associated with aggressive treatment.
A1C does not always show:
This is why modern ADA and ADA/EASD diabetes care looks beyond A1C alone.
People with diabetes have a higher risk of cardiovascular disease, including heart attack, stroke, heart failure, and blood vessel disease.
Modern diabetes management pays close attention to cardiovascular health. In selected patients, especially those with established cardiovascular disease or high cardiovascular risk, doctors may consider medications with evidence of cardiovascular benefit.
This does not mean every patient needs the same medicine. Treatment should reflect the individual's complete clinical situation.
Questions to ask your doctor:
Diabetes is one of the major causes of chronic kidney disease.
Modern ADA and ADA/EASD-style care includes kidney monitoring, often through blood tests estimating kidney function and urine tests measuring albumin.
Kidney health can influence:
Questions to ask your doctor:
For many people with type 2 diabetes, weight affects insulin resistance, blood glucose, blood pressure, fatty liver, sleep apnea, mobility, and cardiovascular risk.
Weight management should be discussed respectfully and medically, with realistic goals and attention to overall health.
Questions to ask your doctor:
Continuous glucose monitoring, or CGM, uses a sensor to measure glucose patterns throughout the day and night.
CGM is widely used in type 1 diabetes and insulin-treated diabetes, while some adults with type 2 diabetes not using insulin may also benefit depending on their clinical needs.
CGM may help identify:
CGM is not necessary for every patient. Clinical benefit, access, costs, training, and patient preferences should be considered.
GLP-1 receptor agonists are medications used to lower blood glucose. Some also support weight loss and have demonstrated cardiovascular or kidney benefits in selected patients.
Examples include semaglutide, liraglutide, and dulaglutide. Related medications may act on multiple hormone pathways, including dual GIP/GLP-1 receptor agonists.
Safety note: GLP-1-related treatments are not suitable for everyone. Adverse effects can include nausea, vomiting, diarrhea, constipation, and other gastrointestinal symptoms. Pregnancy, relevant medical history, medication-specific warnings, dehydration risk, and other conditions require careful clinical evaluation.
Questions to ask your doctor:
SGLT2 inhibitors increase urinary glucose excretion. Certain medicines in this class also provide important heart failure or kidney-related benefits in appropriately selected patients.
Examples include empagliflozin, dapagliflozin, and canagliflozin.
Safety note: SGLT2 inhibitors can increase the risk of genital infections, dehydration, and rarely diabetic ketoacidosis. Ketoacidosis can develop even without markedly elevated blood glucose. Serious illness, prolonged fasting, surgery, dehydration, very low-carbohydrate diets, or heavy alcohol intake may increase risk.
Questions to ask your doctor:
Metformin remains a commonly used treatment for type 2 diabetes when appropriate, safe, and tolerated.
However, modern diabetes treatment does not follow a simple rule of "metformin first for everyone." Some patients may benefit from other therapies earlier, depending on cardiovascular disease, kidney disease, weight, hypoglycemia risk, treatment tolerance, and other clinical needs.
Patients should not stop metformin or other prescribed medicines based on information found online. Treatment decisions should be individualized.
Modern ADA and ADA/EASD diabetes guidelines continue to emphasize lifestyle and self-management support.
Food choices, physical activity, sleep, stress management, smoking cessation, medication adherence, hydration, and regular follow-up all contribute to comprehensive diabetes care.
A treatment plan may include:
The goal is a realistic, sustainable, and safe plan that supports long-term health.
Contact your healthcare professional urgently or seek emergency medical care when appropriate if you experience:
Emergency reminder: Seizures, loss of consciousness, severe confusion, signs of stroke, chest pain, severe breathing difficulty, and suspected diabetic ketoacidosis require emergency medical assessment. Do not wait for online advice. Call your local emergency number.
Explore additional educational resources about diabetes guidelines, glucose levels, and preventing complications.
Historical guidelines and earlier treatment recommendations.
More recent developments in glucose-lowering treatment.
Explore the site's 2026 guidelines-related article.
Common glucose targets before meals, after meals, and at bedtime.
Understand the meaning of blood glucose readings.
A patient-friendly guide to glucose measurements.
Why long-term diabetes management goes beyond blood sugar.
Diabetes care has changed because medical evidence has changed. But the most important message for patients has stayed the same: your treatment should be safe for you.
Do not compare your medication plan with another person's plan. Two patients may have the same A1C but different kidney function, cardiovascular risk, body weight, age, medication tolerance, pregnancy status, or hypoglycemia risk.
Good diabetes care is not only about reaching a number. It is about reaching the right number safely while protecting your overall health.
This page is provided for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before changing diabetes medication, dietary interventions, supplements, exercise plans, or other treatment decisions.